Inactive Instrument

Analyst Reco. STAD VALU Nasdaq

Equities

SVACU

US85521J2087

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

Cyxtera Earns 5-Star Rating in 2023 CRN® Partner Program Guide	13/23/13	BU
Raymond James Downgrades Cyxtera Technologies to Market Perform From Outperform	22/23/22	MT
TD Cowen Downgrades Cyxtera Technologies to Market Perform From Outperform, Adjusts Price Target to $1 From $3	20/23/20	MT
Credit Suisse Trims Cyxtera Technologies' PT to $4 From $5, Says Debt Maturity Uncertainty Weighs on the Stock; Keeps Outperform Rating	17/23/17	MT
Credit Suisse Trims Cyxtera Technologies' PT to $5 From $6, Notes Lowering Gross Margins on Lingering Higher Power Costs; Keeps Outperform Rating	07/23/07	MT
Truist Securities Adjusts Price Target on Cyxtera Technologies to $6 From $15, Maintains Buy Rating	22/22/22	MT
BNP Paribas Initiates Cyxtera Technologies With Underperform Rating, Price Target is $2	14/22/14	MT
Citigroup Adjusts Price Target on Cyxtera Technologies to $2.75 From $13, Maintains Buy Rating	01/22/01	MT
UBS Adjusts Cyxtera Technologies Price Target to $3 From $14, Maintains Neutral Rating	09/22/09	MT
Raymond James Lowers Price Target on Cyxtera Technologies to $7 From $13, Maintains Outperform Rating	09/22/09	MT
RBC Cuts Price Target on Cyxtera Technologies to $9 From $14, Citing Interest Rates, Market Conditions; Outperform Rating Kept	07/22/07	MT
Truist Securities Adjusts Price Target on Cyxtera Technologies to $15 From $20, Reiterates Buy Rating	20/22/20	MT
Citigroup Upgrades Cyxtera Technologies to Buy From Neutral; Price Target is $13	24/22/24	MT
Credit Suisse Lowers Cyxtera Technologies' PT to $13 from $15, Says EBITDA Guide Disappointed, But Demand Remains Strong; Keeps Outperform Rating	12/22/12	MT
Truist Securities Adjusts Price Target on Cyxtera Technologies to $20 From $15, Maintains Buy Rating	08/22/08	MT
RBC Raises Price Target on Cyxtera Technologies to $16 From $14, Maintains Outperform Rating	06/22/06	MT
Credit Suisse Initiates Cyxtera Technologies at Outperform with $15 Price Target, Says Improving Occupancy Potential Underappreciated	07/22/07	MT
RBC Lifts Price Target on Cyxtera Technologies to $14 From $13, Maintains Outperform Rating	30/22/30	MT
Raymond James Adjusts Cyxtera Technologies' Price Target to $13 From $12, Keeps Outperform Rating	23/22/23	MT
William Blair Initiates Coverage on Cyxtera Technologies With Outperform Rating	31/22/31	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. STAD VALU Nasdaq

Equities

SVACU

US85521J2087

Analyst Reco.

Filters